Celldex Therapeutics Stock Price. Everything You Need To Know About The Celldex Therapeutics Stock!
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. The company is headquartered in Hampton, New Jersey and currently employs 148 full-time employees. The company is focused on developing therapeutic monoclonal and bispecific antibodies that address diseases for which available treatments are inadequate. Its drug candidates include antibody-based therapeutics, which has the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis and Eosinophilic Esophagitis. Its bispecific platform includes CDX-585 and CDX-527. CDX-585 combines its active PD-1 blockade and anti-ILT4 blockade to prevent immunosuppressive signals in T cells and myeloid cells, respectively. Its other programs include CDX-1140, a fully human agonist monoclonal antibody targeted to CD40.
Celldex Therapeutics Stock Price. Everything You Need To Know About The Celldex Therapeutics Stock! performance
- Employees 148
- Company HQ Hampton
- Website https://celldex.com/
- CLDX Asset Type Common Stock
- CLDX Market Capitalization 2.4B
- Earnings Per Share -2.92
- Dividends Per Share None
- Dividend Date 2019-02-11
- Quarterly Earnings Growth 0
Investing in Celldex Therapeutics from Malaysia, Thailand, Indonesia, and Vietnam can be a wise choice for retail investors looking to diversify their portfolios. Celldex Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for various diseases, including cancer and infectious diseases. With an experienced team and a robust pipeline of potential therapies, Celldex Therapeutics has garnered attention from investors worldwide. To invest in Celldex Therapeutics stock from the mentioned countries, you can follow these simple steps. First, ensure that you have a brokerage account that allows international stock trading. Research and select a reputable online brokerage platform that caters to investors from Malaysia, Thailand, Indonesia, and Vietnam. Open your account and complete the necessary documentation. Next, fund your account to have access to funds for investing. You can do this through various methods, including bank transfers, debit or credit cards, or alternative payment options depending on your chosen brokerage platform. Once you have funds in your account, search for Celldex Therapeutics’ stock using their ticker symbol on the platform. Review the stock’s performance, historical data, and analyst recommendations to make an informed decision. Consider consulting your financial advisor or doing thorough research before investing. When you decide to invest, determine the number of shares you wish to purchase and place a buy order through your brokerage account. Keep in mind that stock prices can fluctuate, so it is advisable to set limits or stop-loss orders to manage potential risks. Investing in Celldex Therapeutics provides a unique opportunity to support the development of groundbreaking therapeutic solutions while potentially reaping financial returns. Stay updated with the latest news and developments related to the company to make well-informed investment decisions. Remember, investing always carries risks, so it’s important to consult with a financial professional before making any investment decisions.
